Physician profile
Michael Bastani
NPI 1811379365
$3,223.97
in general payments reported to CMS, 2019-2025
18 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.84 · 2020: $373 · 2021: $1,015 · 2022: $114 · 2023: $101 · 2024: $258 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,221 · Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,220.93 |
| Food and Beverage | $436.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,411.52 | 2021-2025 | |
| Stryker Corporation | $576.70 | 2020-2024 | Prostep, Prostep Mica, Citrefix |
| Paratek Pharmaceuticals, INC. | $315.78 | 2020-2021 | |
| Smith+Nephew, INC. | $242.74 | 2019-2025 | Renasys Touch |
| Organogenesis INC. | $141.26 | 2021 | |
| Celularity INC. | $137.58 | 2020 | |
| Zimmer Biomet Holdings, INC. | $103.21 | 2020-2021 | |
| Integra Lifesciences Corporation | $76.97 | 2020-2021 | |
| Depuy Synthes Sales INC. | $44.44 | 2024 | Orthovisc |
| Globus Medical, INC. | $24.95 | 2025 | Senza |
| Nabriva Therapeutics, Plc | $23.33 | 2020 | |
| Averitas Pharma INC. | $22.82 | 2025 | Qutenza |
| Biotissue Holdings INC. | $19.09 | 2024 | |
| Linvatec Corporation | $18.68 | 2021 | |
| Saxum Surgical, INC. | $17.65 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $17.09 | 2021 | |
| Mimedx Group, INC. | $16.83 | 2024 | |
| Arthrosurface Incorporated | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bastani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.